CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI

Press/Media

Period17 Oct 2020

Media coverage

1

Media coverage

  • TitleCeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date17/10/20
    PersonsRoxana Mehran,